Transpire Claims First-Mover Advantage On US Breo Ellipta Rival

Says It Is First To File Paragraph IV ANDA For Fluticasone/Vilanterol

 
• By Dave Wallace
  
Transpire Bio is hoping to be the first to challenge Breo Ellipta in the US (Shutterstock)

More from Generics

More from Products